(Total Views: 578)
Posted On: 03/22/2021 8:34:13 PM
Post# of 154140
“Yet Dr. Patterson said he had been using standard flow cytometry tests he had been using for years. Which would predate the new tests.”
Read the PR regarding completion of the leronlimab RO by Incelldx in July 2019. Incelldx’s use of other ROs prior to that is not relevant as those were for other companies, not CYDY.
“completion of development of the Receptor Occupancy Test to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab.”
Read the PR regarding completion of the leronlimab RO by Incelldx in July 2019. Incelldx’s use of other ROs prior to that is not relevant as those were for other companies, not CYDY.
“completion of development of the Receptor Occupancy Test to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab.”
(0)
(0)
